Record margins, revenue stalled—wealth pivot unproven
Net profit hit ₹735 crore with sector-leading 47.5% margins, but revenue flatlined quarter-on-quarter. Management withheld new product metrics while claiming a strategic shift, and the market has already rendered its verdict: down 14% from its all-time high.
₹1,501.4 Cr
-0.3% QoQ
₹735 Cr
+7.1% QoQ
47.5%
Sector-leading
64.7%
Intact margin structure
The headline profit is strong — ₹735 crore represents one of the best-in-class margins in Indian fintech. But the underlying number tells a different story: revenue flat at -0.3% quarter-on-quarter, with management signalling near-term headwinds ('fairly flattish' Q2 trends in MTF) and deferring all new product metrics as 'too early' to disclose. This is the tension of the quarter: world-class execution on profitability, stalled execution on growth.
Where the profit growth came from
The 7.1% quarter-on-quarter PAT growth masks an important driver: float income benefited from a rate tailwind, not volume strength. CFO Ishan Bansal confirmed that cash yields improved roughly 5% year-on-year, with expectations for 1–2% quarterly gains. This is real but dependent on RBI's rate posture — when rates plateau or reverse, this tailwind disappears. Meanwhile, across the board, volume metrics show stall or decline: cash orders down 9% (gold/silver weakness, ETF slowdown), MTF adoption pending despite a ₹600–700 crore quarterly book growth, and Q2 early-month trends 'fairly flattish' by management's own account.
MTF growing better than expected
OverstatedBook adding ₹600–700 Cr quarterly, but QoQ revenue -0.3% flat; Q2 early trends 'fairly flattish'; adoption pending
Strategic shift to true wealth management company
OverstatedW and MF Prime launched; Fisdom + AMC contribution <2% revenue; W metrics withheld as 'too early'
Cash yields improving ~5% YoY
SupportedCFO confirmed 5% YoY improvement; expect 1–2% quarterly gains as MTF penetration rises
Cost structure disciplined; headcount not increasing
SupportedEmployee cost up from April appraisal cycle, not headcount; ESOP ~10% of Q1 employee expense
Commodities 28% retail market share
SupportedCEO stated >28% retail market share in notional ADTO
What changed on this call
Product execution advanced: Bonds now live and scaling; US stocks licensed via GIFT City; AMC partnership cleared SEBI/CCI
Near-term momentum softened: QoQ revenue -0.3% flat; Q2 early MTF trends 'fairly flattish'
Margin resilience confirmed: OPM 64.7%, NPM 47.5% maintained despite revenue plateau
Metrics withheld deliberately: New product customer numbers, W AUM, US launch timeline flagged as 'too early'
The bull-bear ledger
Sector-leading profitability: 47.5% NPM and 64.7% OPM set Groww apart from peers
Cost discipline proven: ESOP and appraisal-driven (not headcount-driven) cost growth
Product pipeline credible: Bonds live, US stocks licensed, AMC approved—execution is real
Commodities dominance: 28% retail market share is a defensible moat
Revenue growth stalled: QoQ -0.3% and Q2 early weakness signal plateau, not reacceleration
New products immaterial: Fisdom + AMC <2% of revenue; W still in gestation with metrics withheld
Management opaque on quantification: No FY27 revenue, margin, or AUM targets provided
Execution risk on simultaneous launches: Bonds, US stocks, W, AMC scaling in parallel
Risks, ranked by severity
Revenue growth doesn't reaccelerate
HighFlat QoQ revenue (-0.3%) with Q2 early trends weak. If plateau persists, operational leverage expires and margin becomes the ceiling, not the floor.
New product execution falters
HighBonds, US stocks, and W suite all launching in parallel. Simultaneous rollouts strain tech and org bandwidth. No disclosed timelines; risk of diluted focus or missed launches.
Wealth management unproven at scale
MediumW and Fisdom metrics withheld. Affluent retention claimed at ~100%, but cohort size unknown. Unproven P&L profile in the Indian fintech context.
Market volatility and regulatory pressure
MediumF&O margin rules and derivatives slowdown already visible. Data privacy regulations tightening. MTF adoption dependent on market volatility.
Customer acquisition cost inflation
Low-MediumCAC spiked to ₹1,900 from ₹1,400 (prior Q1), driven by IPL sponsorship. Branding benefit claimed but not directly correlated to acquisition.
How the street is positioned
The market's reaction to Q1 has been unambiguous: the stock fell 4.94% on day 1, declining further to -5.96% by day 3 and holding at -5.75% by day 5. The initial decline did not fade, signalling that investors were not convinced by the reported profit and margin story. At ₹194.37, the stock is down 14.37% from its all-time high of ₹227 and trading below both its 50-day and 20-day moving averages.
Institutional positioning has shifted. Foreign portfolio investors (FII) trimmed holdings by 63 basis points quarter-on-quarter to 2.51%, while domestic institutions added marginally. More telling: venture capital and growth-stage investors have been active sellers. Peak XV Partners, YC Holdings, and Ribbit Capital have collectively sold over ₹28 crore in bulk transactions near ₹180–₹181, consistent with taking partial exits at a discount to the all-time high. These are realistic re-valuations of longer-term growth expectations in a plateau scenario.
The debate
1 · Q2 MTF and cash revenue trends
Management flagged Q2 early MTF trends as 'fairly flattish'. If this weakness persists into the full Q2 result, the growth plateau is confirmed and wealth becomes the only credible path forward. A reacceleration would invalidate the bear thesis.
2 · New product traction disclosure
W AUM, Bonds customer count, and US stocks launch timeline remain withheld. When management quantifies these metrics, the market will finally assess the wealth pivot. If numbers are material, the narrative resets; if small, the overstated claim is confirmed.
3 · FY27 guidance quantification
Management reaffirmed strategy but declined to provide FY27 revenue, margin, or AUM targets. If Q2 sees renewed confidence, quantified guidance becomes table stakes to restore institutional interest.
Groww delivered a quarter of steady execution, not step-change growth. The margins are genuine and the product pipeline is real, but the revenue plateau and withheld metrics have justifiably tempered expectations. The 14% drawdown from all-time highs is not irrational.
The single number to track from here is Q2 revenue growth. If that turns positive with new products showing material traction, the debate resolves bull. If it remains flat, the franchise is solid but mature — a high-margin, low-growth story. The market is waiting for evidence; management must provide it.
Strong margins mask revenue stall; wealth pivot unproven
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Reaffirmed strategy without numeric targets. Margin beat implicit in strong delivery. Withheld near-term product metrics.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Exceptional margin quality (47.5% NPM, 64.7% OPM) and strategic positioning toward wealth management are clear strengths. However, Q1 revenue flat QoQ (-0.3%) and Q2 early trends weak, with management citing market volatility and not growth reacceleration. Product pipeline (W, Bonds, US stocks, AMC) is credible but metrics withheld; execution risk on simultaneous launches.
₹1501.4 Cr
Revenue · +null% YoY₹735 Cr
Reported PAT · +null% YoYExpanding
Margins · vs guidance: MixedDid the claims hold up?
MTF growing better than expected
OVERSTATEDQoQ revenue -0.3% flat; Q2 early trends 'fairly flattish'; dependent on market volatility
Strategic shift to true wealth management company
OVERSTATEDW, MF Prime launched but metrics withheld as 'too early'; Fisdom+AMC <2% revenue; no AUM disclosed
Cash yields improving ~5% YoY
METCFO confirmed cash yields up roughly 5% YoY; expect 1-2% quarterly increases
Cost structure disciplined; org count not increasing
METEmployee cost increase due to appraisal cycle not headcount; ESOP ~10% of costs; no crazy headcount growth expected
Commodities 28% retail market share
METCEO stated >28% retail market share in notional ADTO
Earnings quality
What changed since the last call
Product execution advanced
UpgradeBonds now launched & scaling; US stocks licensed (vs prior 'planned'); AMC got SEBI/CCI approval. But traction metrics remain withheld.
Near-term growth softened
DowngradeQoQ revenue -0.3% (flat); Q2 early trends 'fairly flattish' vs prior quarter's momentum. Management attributes to market volatility, not product issues.
Margin resilience confirmed
NeutralOPM 64.7%, NPM 47.5% maintained despite revenue plateau. Cost discipline evident; ESOP ~10% of employee spend.
The Q&A
Analysts pressed on new product metrics (bonds customer count, W AUM, US stocks timeline), CAC jump (IPL spend justified but questioned), MTF growth stall, and future AUM targets. Management deflected on specific numbers, citing 'too early' and privacy concerns. Tone was professional but defensive on quantification.
Employee costs & headcount — Dipanjan Ghosh, Citigroup
AnsweredIncrease due April appraisal cycle, not headcount. Expect tech/AI-driven wealth model; org count not to increase significantly.
MTF adoption & yields — Dipanjan Ghosh, Citigroup
AnsweredAdoption pending; infra improvements expected to boost penetration. Cash yields up ~5% YoY; expect 1-2% gains quarterly.
Derivatives weakness — Dipanjan Ghosh, Citigroup
AnsweredQ4 exception due to volatility. Q1 vs Q3 shows improvement; stabilizing trend. ESOP ~10% of Q1 employee cost.
US stocks launch timeline — Supratim Datta, Jefferies
PartialTesting mode; will launch soon but no exact timeline. Start with US, then assess demand for other geographies. Learning curve product.
F&O margin regulation impact — Supratim Datta, Jefferies
PartialNo SEBI signal on new rules. Impact hard to pinpoint—multiple changes happened in parallel.
Prime & W traction — Supratim Datta, Jefferies
DodgedBit too early. Process is 'build 10x product, go slow, then run fast.' More color in coming quarters.
Strategy across multiple products — Prayesh Jain, Motilal Oswal
AnsweredAll products at different life stages. Core business gets more efficient; new products from existing teams via pod structure. Confident in progress.
Wealth AUM aspirations — Prayesh Jain, Motilal Oswal
DodgedBit early. Very confident and happy with progress seen; numbers in coming calls.
Risk to earnings profile — Prayesh Jain, Motilal Oswal
DodgedNothing top of mind currently.
MTF momentum Q2 weakness — Swarnabh Mukherjee, 360 One
AnsweredMarket at Q-end bullish; now volatile. MTF correlated with volatility more than regulation. Q4 anomaly (negative close); Q1 positive close boosted number.
MAU/DAU stagnation — Swarnabh Mukherjee, 360 One
AnsweredQ4 was volatility anomaly; Q1 better vs Q3. Comparison should exclude Q4. Adding ₹600–700 Cr MTF quarterly.
Cash yield stabilization — Swarnabh Mukherjee, 360 One
PartialHard to estimate. MTF strong but multiple variables (ticket size, rate changes). Near-term expect increases; long-term uncertain.
CAC per NTU surge — Sanketh Godha, Avendus
AnsweredIPL in Q1 (2 months) vs Q4 (1 week). Branding benefit; not directly correlated to acquisition. Without IPL would be lower.
Cash revenue breakdown — Sanketh Godha, Avendus
DodgedWon't disclose. Too much detail; INR5 minimum, MIS complexity. Average is what you work with.
Fisdom momentum — Sanketh Godha, Avendus
AnsweredNo significant improvement yet. Still in gestation stage. Will talk when more relevant.
Cost to operate trend — Abhijeet Sakhare, Kotak
AnsweredSlight improvement; Q4 had one-time risk costs. Expect continuation with slight inflationary increases.
Affluent customer retention — Abhijeet Sakhare, Kotak
AnsweredSignificantly better than peers; ~100%. AUM stickiness + long-term habit + quality base = very high retention.
Cohort acquisition quality — Nidhesh Jain, Investec
PartialFY26 acquisition quality better. ARPU improving as platform matures. Data still building; will share later.
MTF average yield — Manish Ostwal, Nirmal Bang
AnsweredFixed pricing 14.95% charged on balance. Slight delta vs average due to timing; roughly 14.95%.
AI business impact — Manish Ostwal, Nirmal Bang
AnsweredProduct development (engineers use AI, build faster/parallel). Customer support (faster query resolution, context). UX edge cases (GR1 handles niche requests). Investing decision support.
3–4 year product roadmap — Dheeraj Kumar Reddy, TVF Capital
PartialHard to predict 3–4 years. Current 1–2 year pipeline very strong: W (mammoth suite), Bonds (launched, scaling), US stocks (launching soon). Best products never done-done.
Bonds & W customer metrics — Dheeraj Kumar Reddy, TVF Capital
DodgedGood indication but numbers too nascent. Will share in coming calls.
Personalization & data usage — Dheeraj Kumar Reddy, TVF Capital
PartialPrivacy important. Do things to help customers but careful about perception. Some data used for UX; may do more carefully.
Guidance
No specific FY27 revenue target quantified
LowReaffirmed strategic shift to wealth mgmt but declined to provide revenue/margin/AUM targets. Vague on product-line guidance.
Cost to operate to continue with slight inflationary increases
MediumQ1 benefited from one-time Q4 costs; expect normalization + 1–2% annual inflation.
No margin expansion targets; OPM/NPM levels to be sustained
Medium47.5% NPM and 64.7% OPM maintained despite revenue plateau; operational leverage from existing business.
No explicit capex guidance; investment in tech, AI, new products ongoing
MediumScale-up investments in wealth platforms (W, Prime) and new products (US stocks) expected; no quantum disclosed.
Risks the call surfaced
Revenue growth stalled
MediumQoY revenue flat (-0.3%); Q2 early MTF trends weak. Volume-dependent on market volatility. If growth doesn't reaccelerate, margin leverage expires.
New product execution risk
HighCompany building W (wealth suite), Bonds (scaling), US stocks (testing), AMC (early), Fisdom (gestation) in parallel. Metrics withheld 'too early.' Risk of dilution, cost overruns, or missed timelines.
Market & regulatory volatility
MediumNovember 24 margin rule and potential June/July rule on expiry day margins. Iran war volatility impacting F&O volume. Data personalization limited by privacy concerns.
Wealth management unproven
MediumW, MF Prime, affluent/HNI targeting launched but no disclosed AUM, customer count, or retention metrics. Affluent retention ~100% claimed but cohort size unknown. Wealth is capital-light but unproven margin profile.
Acquisition cost inflation
LowCAC jumped to ₹1,900 from ₹1,400 (prior Q1) and ₹1,000 (Q4). IPL sponsorship (2 months Q1 vs 1 week Q4) cited as driver. Branding benefit claimed but not directly correlated to acquisition volumes.
Management
Score 6/10. Professional and structured but evasive on quantified metrics. Deflected on new product customer numbers, wealth AUM targets, future risk scenarios citing 'too early' or 'nothing top of mind.' Clear on strategy but vague on execution timelines. Track record intact: Bonds launched and scaling; US stocks licensed; AMC partnership secured (SEBI/CCI approval). But near-term momentum soft (revenue -0.3% QoQ); Q2 trends weak (MTF flat). New products still nascent (Fisdom <2% revenue).
1 · H2 FY27
US stocks launch (GIFT City license obtained)
2 · Q2 FY27
Bonds uptick / new product TBD; AMC partnership revenue ramp
3 · FY27–28
W wealth suite scale-up for affluent/HNI cohort
Product pipeline (W, Bonds, US stocks, AMC) is credible but metrics withheld; execution risk on simultaneous launches.